Science Explorer Back to mapMap
Discussion
Researcher · Bexion Pharmaceuticals (United States) · United States

Michael Gazda

Michael Gazda publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Sphingolipid Metabolism and Signaling, Cancer, Lipids, and Metabolism and Cancer Treatment and Pharmacology.

OpenAlex
World rank
#5,268,801
of 7,710,434 ranked researchers
Rank in United States
#1,346,650
of 1,627,098
Works
17
Citations
26
Citations per work
1.5
h-index
2
i10-index 1Top 99.5% in Molecular Biology
Michael Gazda

What does Michael Gazda research?

Michael Gazda's work is mostly in Biochemistry, Genetics and Molecular Biology (54%), Medicine (23%).

Life Sciences: 9 works · 54.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 54.2% of their workMolecular Biology: 5 works · 31.3% of their workCancer Research: 2 works · 14.6% of their workCell Biology: 1 works · 8.3% of their workHealth Sciences: 4 works · 23.0% of their workMedicine: 4 works · 23.0% of their workOncology: 2 works · 14.6% of their workPsychiatry and Mental health: 1 works · 4.2% of their workSurgery: 1 works · 4.2% of their workEverything else: 4 works · 22.8% of their workTHEIR WORKMichael Gazda17works
Life Sciences54%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology954.2%
    1. Medicine423.0%
  3. Everything else422.8%
  1. 1Molecular Biology31% of their works
  2. 2Oncology15% of their works
  3. 3Cancer Research15% of their works
  4. 4Cell Biology8% of their works
  5. 5Psychiatry and Mental health4% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Michael Gazda's research?

The keywords of their largest research topics: Cancer, Sphingolipids, Sphingosine-1-Phosphate, Fatty Acid Synthase, Lipid Metabolism, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and Caveolae.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer172 topics
  2. Sphingolipids111 topic
  3. Sphingosine-1-Phosphate111 topic
  4. Fatty Acid Synthase61 topic
  5. Lipid Metabolism61 topic
  6. Chemotherapy-Induced Peripheral Neuropathy51 topic
  7. Taxanes51 topic
  8. Caveolae41 topic
  9. Caveolin41 topic
  10. ATP Synthase31 topic
  11. Vacuolar ATPases31 topic
  12. Cetuximab21 topic
  13. Encephalopathy21 topic
  14. KRAS Mutations21 topic
  15. Kidney Transplantation21 topic
  16. Renal Allograft21 topic
  17. Reversible21 topic

Where does Michael Gazda work?

Michael Gazda's main affiliation in the publication record is Bexion Pharmaceuticals (United States), United States.

How many publications and citations does Michael Gazda have?

OpenAlex counts 17 works and 26 citations for Michael Gazda, an h-index of 2, ranking #5,268,801 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Gazda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.